Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in Australia

被引:0
|
作者
Barbara de Graaff
Kwang Chien Yee
Philip Clarke
Andrew Palmer
机构
[1] University of Tasmania,Menzies Institute for Medical Research
[2] University of Tasmania,School of Medicine
[3] University of Melbourne,School of Population and Global Health
来源
Applied Health Economics and Health Policy | 2018年 / 16卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:495 / 502
页数:7
相关论文
共 50 条
  • [21] Microbiota and hepatitis C virus in the era of direct-acting antiviral agents
    Pinchera, Biagio
    Moriello, Nicola Schiano
    Buonomo, Antonio Riccardo
    Zappulo, Emanuela
    Viceconte, Giulio
    Villari, Riccardo
    Gentile, Ivan
    MICROBIAL PATHOGENESIS, 2023, 175
  • [22] Update on hepatitis C virus resistance to direct-acting antiviral agents
    Poveda, Eva
    Wyles, David L.
    Mena, Alvaro
    Pedreira, Jose D.
    Castro-Iglesias, Angeles
    Cachay, Edward
    ANTIVIRAL RESEARCH, 2014, 108 : 181 - 191
  • [23] Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights
    Gotte, Matthias
    Feld, Jordan J.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2016, 13 (06) : 338 - 351
  • [24] Direct-acting antiviral agents for the treatment of HCV
    Thompson, Alexander J.
    Locarnini, Stephen
    ANTIVIRAL THERAPY, 2012, 17 (06) : 1105 - 1107
  • [25] RACIAL DISPARITY IN CHRONIC HEPATITIS C TREATMENT SUCCESS WITH DIRECT-ACTING ANTIVIRAL AGENTS.
    Koppala, Jahnavi
    Alam, Mobashshir
    Walters, Ryan W.
    Rao, Sirish
    Baker, Elliott
    Osman, Ali H.
    Chandra, Subhash
    Mukherjee, Sandeep
    GASTROENTEROLOGY, 2020, 158 (06) : S494 - S494
  • [26] SASLT Position Statement on the Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection
    Alghamdi, Abdullah S.
    Alqutub, Adel
    Abaalkhail, Faisal
    Sanai, Faisal M.
    Alghamdi, Hamdan
    Altraif, Ibrahim
    Alswat, Khalid A.
    Alghamdi, Mohammed Y.
    Babatin, Mohammed A.
    Alfaleh, Faleh Z.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2015, 21 (02): : 60 - 63
  • [27] Real-world experiences with direct-acting antiviral agents for chronic hepatitis C treatment
    Daniel, Kimberly E.
    Saeian, Kia
    Rizvi, Syed
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (02) : 195 - 204
  • [28] Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection
    Fernandez-Yunquera, Ainhoa
    Rincon, Diego
    Salcedo, Magdalena
    Banares, Rafael
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2013, 26 (03) : 189 - 192
  • [29] CHRONIC HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRAL AGENTS IN A REAL-LIFE SETTING
    Ann Chirino-Sprung, Ruby
    Dehesa, Margarita
    Wolpert, Enrique
    Corona-Lau, Clara
    Garcia-Juarez, Ignacio
    Francisco Sanchez-Avila, Jose
    Moctezuma-Velazquez, Carlos
    Kershenobich, David
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2016, 68 (04): : 201 - 209
  • [30] Interferon-α/β for treatment of chronic hepatitis C infection in the era of direct-acting antiviral agents
    Enomoto, Masaru
    Tamori, Akihiro
    Murakami, Yoshiki
    Kawada, Norifumi
    HEPATOLOGY RESEARCH, 2014, 44 (04) : 371 - 376